Predictors of Recurrence Following Sublobar Resection for Clinical T1N0M0 Non-Small Cell Lung Cancer
1Division of Thoracic and Esophageal Surgery, Cardiovascular Institute, Allegheny Health Network, Pittsburgh, Pennsylvania.
For lung cancer patients undergoing sublobar resection, adequate surgical margins and thorough lymph node dissection are key to reducing recurrence. Prioritizing these modifiable factors improves long-term survival outcomes.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Recurrence after sublobar resection for early-stage lung cancer (T1N0M0) is a significant clinical challenge.
- Identifying and addressing modifiable risk factors is crucial for improving patient outcomes.
Purpose of the Study:
- To review and analyze recurrence risk factors following sublobar resection for clinical T1N0M0 lung cancer.
- To focus on disease stage, tumor characteristics, and surgeon-related factors influencing recurrence.
Main Methods:
- Systematic review and analysis of data from randomized trials and retrospective studies.
- Assessment of the impact of tumor biology, stage, surgical margins, and lymph node dissection on recurrence rates.
Main Results:
- Recurrence is multifactorial, influenced by tumor stage, biology, and surgical technique.
- Inadequate surgical margins (less than ≥1 cm or tumor diameter) and incomplete lymph node dissection significantly increase recurrence risk.
- Systematic nodal dissection improves staging accuracy and guides adjuvant therapy decisions.
Conclusions:
- Surgical margins and lymph node dissection are the most critical modifiable risk factors for recurrence after sublobar resection.
- Prioritizing adequate margins and systematic nodal evaluation is essential for optimizing long-term survival.
- Further research is needed on completion lobectomy or adjuvant therapy in high-risk patients.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
